1.Establishment and evaluation of methods for determinating cystic fibrosis transmembrane conductance regulator quantitatively.
Feng QIU ; Jie ZENG ; Kun LI ; Ai-jun CHEN ; Wan-xiang XU ; Ya NI
Chinese Journal of Applied Physiology 2015;31(2):154-157
OBJECTIVETo establish and evaluate a BA-ELISA method for the quantitative detection of cystic fibrosis transmembrane conductance regulator (CFTR) protein.
METHODSWe deliberately selected three tables of CFTR and made the synthetic peptide be expressed in E. coli, then used the antigen to immunize rabbits to obtain the anti-CFTR polyclonal serum. After that, 96 well plates were coated with the purified antibody against CFTR. The antigen CFTR which was extracted from human sperm was detected by anti-CFTR antibody labeled with biotin, horseradish peroxidase conjugated avidin, and the substrate. The concentrations of two kinds of antibodies and the experiment parameters were optimized. Thereby, the double antibody sandwich BA-ELISA method for the quantitative detection of CFTR protein was established. Furthermore, the reproducibility, specificity and so on were evaluated by clinical specimens of sperm.
RESULTSThe optimal concentration of coated anti-CFTR IgG was 4 µg/ml, while the biotin labeled anti-CFTR IgG was 10 µg/ml; the optimal blocking buffer was 1% BSA-PBST, the optimal time of the reaction between antigen and antibody was 60 min, the optimal chromogenic time was 15 min, the intra-assay and inter-assay coefficient were 2.16%-9.23% and 2.29%-11.71% respectively; The lowest detectable limit was 0.15 ng/ml; the standard curve had a good linear correlation of R2 = 0.962.
CONCLUSIONThe BA-ELISA method for the quantitative detection of CTFR protein is successfully established, and it is demonstrated that the method has strong specificity, high sensitivity and good reproducibility. It provides the basis and evidence of the further application of the method.
Animals ; Antibodies ; Cystic Fibrosis Transmembrane Conductance Regulator ; analysis ; Enzyme-Linked Immunosorbent Assay ; methods ; Escherichia coli ; Humans ; Peptides ; Rabbits ; Reproducibility of Results ; Sensitivity and Specificity
3.Resolvin E1 protects against ox-LDL-induced injury on vascular endothelial cells
Ya-Feng CHEN ; Hong JIANG ; Xia GONG ; Jing-Yuan WAN
Chinese Journal of Cardiology 2011;39(11):1039-1043
Objective To investigate whether Resolvin E1 ( RvE1 ) could protect against ox-LDL-induced injury on human vein vascular endothelial cells and reveal related molecular mechanisms.Methods Human vein vascular endothelial cells were randomly assigned to six groups,which were treated with saline,RvE1,wortmanin,ox-LDL,ox-LDL and RvE1,ox-LDL and RvE1 and wortmanin,respectively.After 48 h,survival rates were determined by MTT,apoptosis rate of cells were determined by flow cytometry,TNF-αt contents were assayed by ELISA,caspase 3 and 9 activities were measured by microplate reader,and the expression of p-AKT and LOX-1 were determined by Western blot.Result Compared with normal saline group,survival rate was markedly decreased and apoptosis rate,TNF-α content,caspase 3 and 9 activities,and the expression of LOX-1 were significantly increased in ox-LDL group ( P < 0.01 ).Survival rate was significantly increased and apoptosis rate,TNF-α content,caspase 3 and 9 activities,and the expression of LOX-1 were significantly decreased in ox-LDL + RyE1 group compared to ox-LDL group (P < 0.01 ),these beneficial effects of RvE1 could be blocked by PI3K inhibitor wortmanin ( P < O.05 ).Conclusion The present data showed that RvE1 could effectively protect against ox-LDL-induced endothelial cell injury,which might be mediated by PI3K-AKT signaling pathway.
4.Limb preservation surgery combined with perioperative rehabilitation for the treatment of 7 patients with stage II to III giant cell tumor of bone in the proximal humerus.
Wan-Qing LU ; Qing-Tian XIANG ; Hong-Guang ZUO ; Ya-Jun YU ; Zhen-Guo PAN ; Feng-Dong ZHAO
China Journal of Orthopaedics and Traumatology 2011;24(12):1032-1035
OBJECTIVETo study the effects of the extensive resection of the tumor-loading segment and artificial humerus head replacement combined with perioperative rehabilitation for the treatment of stage II to III giant cell tumor of bone in the proximal humerus.
METHODSFrom March 2007 to March 2010, 7 patients with stage II to III giant cell tumor of bone in the proximal humerus were treated. Among the patients, 3 patients were male and 4 patients were female with a mean age of 34.6 years (ranged, 18 to 49 years). The mean course of disease was 19 months (ranged, 6 to 35 months). All the patients were confirmed to suffer stage II to III giant cell tumor of bone in the proximal humerus by pathology and X-ray examinations. Clinical manifestations of the patients included persistence aggravated pain of the shoulder, swelling in the proximate arm with obviously tenderness, activity limited of the joint. All the patients were treated with extensive resection of the tumor-loading segment and artificial humerus head replacement combined with perioperative rehabilitation. CMS and OSIS score system were used to evaluate shoulder function and shoulder stability.
RESULTSAll the patients were followed up, and the duration ranged from 14 to 35 months, with an average of 17 months. There were no serious complications or recurrence in all cases. One year after the surgery CMS and OSIS score system were 70.7 scores (ranged,63 to 82 scores) and 25.1 scores (ranged, 18 to 29 scores) respectively. According to evaluation for shoulder function, 2 patients got an excellent result and 5 good. According to evaluation of shoulder stability, 1 patient got an excellent result and 6 good.
CONCLUSIONExtensive resection of the tumor-loading segment and artificial humerus head replacement combined with perioperative rehabilitation for the treatment of stage II to III giant cell tumor of bone in the proximal humerus would not only preserve the upper extremity but also preserve the function of upper extremity.
Adolescent ; Adult ; Bone Neoplasms ; pathology ; rehabilitation ; surgery ; Female ; Giant Cell Tumor of Bone ; pathology ; rehabilitation ; surgery ; Humans ; Humerus ; surgery ; Limb Salvage ; Male ; Middle Aged ; Neoplasm Staging
5.Transcriptome profiling and analysis of Panax japonicus var. major.
Shao-peng ZHANG ; Jian JIN ; Bing-xiong HU ; Ya-yun WU ; Qi YAN ; Wan-yong ZENG ; Yong-lian ZHENG ; Zhang XI-FENG ; Ping CHEN
China Journal of Chinese Materia Medica 2015;40(11):2084-2089
The rhizome of Panax japonicus var. major have been used as the natural medicinal agent by Chinese traditional doctors for more than thousand years. Most of the therapeutic effects of P. japonicus var. major had been reported due to the presence of tetracyclic or pentacyclic triterpene saponins. In this study, Illumina pair-end RNA-sequencing and de novo splicing were done in order to understand the pathway of triterpenoid saponins in this species. The valid reads data of 15. 6 Gb were obtained. The 62 240 unigenes were finally obtained by de novo splicing. After annotation, we discovered 19 unigenes involved in ginsenoside backbone biosynthesis. Additionally, 69 unigenes and 18 unigenes were predicted to have potential function of cytochrome P450 and UDP-glycosyltransferase based on the annotation results, which may encode enzymes responsible for ginsenoside backbone modification. This study provides global expressed datas for P. japonicus var. major, which will contribute significantly to further genome-wide research and analysis for this species.
Gene Expression Profiling
;
Panax
;
genetics
;
Saponins
;
biosynthesis
;
Sequence Analysis, RNA
6.Treating primary liver cancer patients by Pi-strengthening and Qi-regulating method: univariate and multivariate analyses of their prognoses.
Xiao-Bing YANG ; Shun-Qin LONG ; Wan-Yin WU ; Hong DENG ; Zong-Qi PAN ; Wen-Feng HE ; Yu-Shu ZHOU ; Gui-Ya LIAO
Chinese Journal of Integrated Traditional and Western Medicine 2014;34(2):162-166
OBJECTIVETo evaluate the prognostic factors in treating primary liver cancer (PLC) patients by Pi-strengthening and qi-regulating method (PSQRM), thus providing evidence and optimizing Pi-strengthening and qi-regulating program.
METHODSClinical data of 151 PLC patients treated by PSQRM at Oncology Department, Guangdong Provincial Hospital of Traditional Chinese Medicine from May 2007 to March 2009 were retrospectively analyzed. The univariate analysis was determined to analyze possible prognostic factors. Selected key factors were introduced into the COX proportional hazard model, and multivariate analysis was carried out.
RESULTSThe 1-year survival rate was 21.85%, the median survival time was 6.80 months, and the mean survival time was 8.98 months. The univariate analysis showed that Chinese medicine (CM) syndrome types, clinical symptoms at the initial diagnosis, ascites, tumor types, ratios of foci, portal vein tumor thrombus, intrahepatic metastasis, a-fetoprotein (AFP) levels, total bilirubin classification, albumin classification, Child-Pugh classification, and domestic staging of liver cancer were significant prognostic factors (P < 0.05). The statistic data of multivariate analysis indicated that CM syndrome types, ascites, tumor types, portal vein tumor thrombus, AFP levels, Child-Pugh classification, and domestic staging of liver cancer were independent factors influencing prognosis (P < 0.05).
CONCLUSIONThe prognosis of PLC treated with PSQRM is determined by multiple factors including CM syndrome types, ascites, tumor types, portal vein tumor thrombus, AFP levels, Child-Pugh classification, and domestic staging of liver cancer.
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular ; epidemiology ; therapy ; Female ; Humans ; Liver Neoplasms ; epidemiology ; therapy ; Male ; Medicine, Chinese Traditional ; methods ; Middle Aged ; Multivariate Analysis ; Prognosis ; Retrospective Studies ; Survival Rate ; Treatment Outcome
7.Role of rennin-angiotensin system in cholinergic agonist carbachol-induced cardiovascular responses in ovine fetus.
Chun-Song GENG ; Zhen WAN ; Ya-Hong FENG ; Yi-Sun FAN
Acta Physiologica Sinica 2012;64(3):303-307
To investigate the mechanisms underlying the cholinergic agonist carbachol-induced cardiovascular responses, changes of renin-angiotensin system were examined in fetal hormonal systems. In the ovine fetal model under stressless condition, the cardiovascular function was recorded. Blood samples were collected before (during baseline period) and after the intravenous administration of carbachol. Simultaneously, the levels of angiotensin I (Ang I), angiotensin II (Ang II) and vasopressin in the fetal plasma were detected by immunoradiological method. Also, blood gas, plasma osmolality and electrolyte concentrations were analyzed in blood samples. Results showed that in chronically prepared ovine fetus, intravenous infusion of carbachol led to a significant decrease of heart rate (P < 0.05), and a transient decrease followed by an increase of blood pressure (P < 0.05) within 30 min. After the intravenous infusion of carbachol, blood concentrations of Ang I and Ang II in near-term ovine fetus were both significantly increased (P < 0.05); however, blood concentration of vasopressin, values of blood gas, electrolytes and plasma osmolality in near-term ovine fetus were not significantly changed (P > 0.05). Blood levels of Ang I and Ang II in the atropine (M receptor antagonist) + carbachol intravenous administration group was lower than those in the carbachol group without atropine administration (P < 0.05). In conclusion, this study indicates that the near-term changes of cardiovascular system induced by intravenous administration of carbachol in ovine fetus, such as blood pressure and heart rate, are associated with the changes of hormones of circulatory renin-angiotensin system.
Angiotensin I
;
blood
;
Angiotensin II
;
blood
;
Animals
;
Blood Pressure
;
Carbachol
;
pharmacology
;
Cholinergic Agonists
;
pharmacology
;
Fetus
;
Heart Rate
;
Renin-Angiotensin System
;
Sheep
;
Vasopressins
;
blood
8.Prognostic value of cyclin E and its relation to blood vessel invasion in rectal cancer.
Yong-Jian ZHOU ; Feng-Ling WAN ; Li-Hua YAO ; Li-Ya FENG
Chinese Journal of Gastrointestinal Surgery 2008;11(2):167-171
OBJECTIVETo investigate the expression of cyclin E in rectal carcinoma and its prognostic significance.
METHODSCyclin E expression was examined by Western blotting in tumor tissue samples from 130 potentially resected rectal cancer patients with pathological stages I- III. Blood vessel invasion (BVI) was detected by immunohistochemistry. Multivariate analysis using the COX proportional hazards models was applied to evaluate the independent prognostic tumor markers of rectal cancer.
RESULTSThe high expression rate of cyclin E in rectal carcinoma tissue was 23.1%(30/130). Except for a positive correlation with BVI and the gross configuration of tumor, the expression of cyclin E showed no significant relation to other clinicopathological factors. The 5-year disease-specific survival rate of cyclin E high expression group was 29.2%, which was significantly lower as compared to that of cyclin low expression group 70.5% (P<0.05). Multivariate analysis revealed that histology and cyclin E expression were independent prognostic indicators for rectal cancer patients at stages I- III. Compared to those with low expression levels, patients with high cyclin E levels had the hazard ratio (95%CI) for death from rectal cancer for 3.544 (1.528-8.215). In stage I- II, multivariate analysis showed that stronger predictive values of cyclin E expression even were detected. Patients with low cyclin E expression and negative BVI had a significantly better prognosis than those with high cyclin E expression and positive BVI.
CONCLUSIONSThe expression of cyclin E is independent prognostic factor in rectal carcinoma at stages I- III. Detecting the expression of cyclin E and/or combined with BVI may help to predict clinical outcome and design further individualized intensive adjuvant treatment.
Adult ; Aged ; Aged, 80 and over ; Cyclin E ; metabolism ; Female ; Humans ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Staging ; Neovascularization, Pathologic ; Prognosis ; Rectal Neoplasms ; blood supply ; metabolism ; pathology ; Survival Rate
9.Experimental study of SHP-1 promoter methylation in myelodysplastic syndromes and its related mechanism.
Yi-Zhuo ZHANG ; Dan-Dan ZHAO ; Wei-Peng ZHAO ; Hai-Feng ZHAO ; Zhi-Gang ZHAO ; Ya-Fei WANG ; Xiao-Xiong WU ; Xiao-Ping HAN ; Wan-Ming DA
Chinese Journal of Hematology 2012;33(2):108-112
OBJECTIVETo explore the role of SHP-1 promoter methylation on the pathogenesis and progression in myelodysplastic syndromes (MDS) and its related mechanism.
METHODS63 MDS patients were divided into low-grade (LG) group and high-grade (HG) group according to IPSS score system. Bone marrow samples were collected. Methylation specific-PCR (MSP) were used to detect the status of SHP-1 promoter methylation in bone marrow (BM) samples from different risk MDS patients and MDS cell line, SKK-1. Western blot was used to detect signal transduction and activator of transcription (STAT3) activation in SKK-1 cell line and MDS patients.
RESULTSNo SHP-1 promoter methylation could be detected in healthy controls BM. Partially methylation was found in SKK-1 cell line. Methylation rate of SHP-1 gene promoter was found in BM of 24.2% of low-grade MDS patients and 63.3% of high-grade MDS patients, the difference between these two groups was statistically significant (P < 0.05); Patients were divided into different groups according to WHO subtype, chromosomal karyotype and blast cells in bone marrow, methylation rates of SHP-1 were significantly higher in RAEB-II, poor karyotype group and samples with 0.11-0.19 blast cells (P < 0.05); The phosphorylation protein of STAT3 was detected in SKK-1 cell line. The expression of phosphorylation STAT3 was significantly higher in HG group than in LG group (66.7% vs 18.2%) (P < 0.05). There was a significant correlation between SHP-1 promoter methylation and STAT3 phosphorylation.
CONCLUSIONAbnormal methylation of SHP-1 gene promoter might have tentative role in the pathogenesis and progression of MDS, which may be involved in STAT3 activation. Detection of SHP-1 promoter methylation may be helpful to evaluate the prognosis of MDS.
Adolescent ; Adult ; Aged ; Case-Control Studies ; Child ; DNA Methylation ; Female ; Humans ; Male ; Middle Aged ; Myelodysplastic Syndromes ; genetics ; metabolism ; Prognosis ; Protein Tyrosine Phosphatase, Non-Receptor Type 6 ; genetics ; metabolism ; STAT3 Transcription Factor ; metabolism ; Young Adult
10.Interaction effects of breastfeeding and passive smoking on asthma and asthma related symptoms among children.
Yu-qin LIU ; Yang ZHAO ; Miao-miao LIU ; Da WANG ; Ya-nan MA ; Wan-hui REN ; Feng GAO ; Guang-hui DONG
Chinese Journal of Preventive Medicine 2013;47(6):523-528
OBJECTIVETo evaluate the interaction effects of breastfeeding and passive smoking on asthma and asthma related symptoms among children.
METHODSUsing a cluster random sampling method, 2 elementary schools and 1 kindergarten were randomly selected from 7 cities of Liaoning province. The resulting 25 elementary schools and 50 kindergartens were included, and 31 049 children from the selected schools living up to 2 years were recruited in this survey. The information about the children's type of feeding up, living environment, passive smoking exposure, respiratory diseases and symptoms were collected. The interaction effects of breastfeeding and passive smoking on asthma and asthma related symptoms (persistent cough,persistent phlegm, current wheeze and allergic rhinitis) were evaluated with Glimmix procedure.
RESULTSThere were 31 049 children involved in this investigation. The age was (8.32 ± 2.75) years old. There were 23 987 (77.26%) children with breastfeeding and 11 820 (38.07%) children with passive smoking. The prevalence of asthma and allergic rhinitis were 6.22%(1491/23 987), 4.67%(1120/23 987) in children with breastfeeding, and were 7.70%(544/7062), 5.48%(387/7062) in children without breastfeeding,compared to the children without breastfeeding, the children with breastfeeding had lower risk of asthma(OR = 0.79, 95%CI:0.72-0.88) and allergic rhinitis(OR = 0.85, 95%CI:0.75-0.95); The prevalence of current wheeze was 7.89%(929/11 770) in children with father smoking, and was 5.37%(1036/19 279) in children without father smoking, compared to the children without father smoking, the children with father smoking increased the risk of current wheeze(OR = 1.51, 95%CI:1.38-1.65). The prevalence of persistent cough was 18.96%(51/269) in children with mother smoking, and was 9.51%(2926/30 780) in children without mother smoking,compared to the children without mother smoking, the children with mother smoking increased the risk of persistent cough(OR = 2.23, 95%CI:1.64-3.03). The prevalence of persistent phlegm was 5.69%(871/5316) in children with anyone smoking, and was 3.50%(550/15 733) in children without anyone smoking, compared to the children without anyone smoking, the children with anyone smoking increased the risk of persistent phlegm(OR = 1.67, 95%CI:1.49-1.86).Glimmix procedure analysis showed there was a significant interaction effects between breastfeeding and passive smoking. The estimated OR for father smoking among breastfeeding children were consistently lower than those among non-breastfeeding children for asthma. The estimated OR for mother smoking among breastfeeding children were consistently lower than those among non-breastfeeding children for allergic rhinitis. The estimated OR for anyone smoking among breastfeeding children were consistently lower than those among non-breastfeeding children for asthma and allergic rhinitis(all P values < 0.05).
CONCLUSIONBreastfeeding decreases the detrimental effects of passive smoking on asthma and asthma related symptoms in children.
Adolescent ; Asthma ; epidemiology ; Breast Feeding ; Child ; Child, Preschool ; Female ; Humans ; Male ; Risk Factors ; Smoking ; Surveys and Questionnaires ; Tobacco Smoke Pollution ; adverse effects